Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta-Endorphin cerebrospinal fluid decrease in untreated parkinsonian patients.

G Nappi, F Petraglia, E Martignoni

    Neurology
    |September 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen.

    Anticancer research·2001
    Same author

    Serum allopregnanolone in women with postpartum "blues".

    Obstetrics and gynecology·2001
    Same author

    The use of a starting dose of recombinant follicle stimulating hormone for controlled ovarian hyperstimulation: a randomized pilot study.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000
    Same author

    Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000
    Same author

    Ovarian follicular fluid contains immunoreactive estriol: lack of correlation with estradiol concentrations.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000
    Same author

    Dose-response efficacy of a new estradiol transdermal matrix patch for 7-day application: a randomized, double-blind, placebo-controlled study. Italian Menopause Research Group.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000
    Same journal

    Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

    Neurology·2026
    Same journal

    Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

    Neurology·2026
    Same journal

    Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

    Neurology·2026
    Same journal

    Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

    Neurology·2026
    Same journal

    Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

    Neurology·2026
    Same journal

    At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

    Neurology·2026
    See all related articles

    Parkinson's disease is linked to lower levels of beta-endorphin (beta-EP) in cerebrospinal fluid (CSF). This finding suggests a broader brain dysfunction beyond the substantia nigra in Parkinson's patients.

    Area of Science:

    • Neuroscience
    • Endocrinology

    Background:

    • Parkinson's disease (PD) is a neurodegenerative disorder primarily affecting motor function.
    • The role of neuropeptides and hormones in PD pathogenesis is not fully understood.

    Purpose of the Study:

    • To investigate cerebrospinal fluid (CSF) and plasma levels of beta-endorphin (beta-EP), beta-lipotropin (beta-LPH), and ACTH in Parkinson's disease patients.
    • To determine if these levels differ between untreated and treated PD patients and controls.

    Main Methods:

    • Measurement of beta-EP, beta-LPH, and ACTH in CSF and plasma samples.
    • Comparison of levels between 24 PD patients (14 untreated) and 15 healthy controls.

    Main Results:

    • CSF beta-EP concentrations were significantly lower in untreated PD patients compared to controls (p < 0.005).

    Related Experiment Videos

  • No significant differences in CSF beta-EP were found between treated and untreated PD patients.
  • CSF ACTH and beta-LPH, and plasma levels of beta-EP, beta-LPH, and ACTH were comparable across all groups.

    • Conclusions:

    • Reduced CSF beta-EP levels in Parkinson's disease support the hypothesis of a generalized brain disorder.
    • The findings suggest that PD may involve broader neurochemical alterations affecting more than dopaminergic systems.